Status:
UNKNOWN
Study of the Effect of Moxonidine and Diet on Sympathetic Functions in Young Adults With Obesity
Lead Sponsor:
Baker Heart and Diabetes Institute
Conditions:
Obesity
Overweight
Eligibility:
MALE
18-30 years
Phase:
PHASE4
Brief Summary
The prevalence of obesity is increasing rapidly among adults and has more than doubled in the past 10 years. The metabolic syndrome (MS) is often associated with obesity. It is characterized by abdomi...
Eligibility Criteria
Inclusion
- Males age between 18 to 30 years old
- Abdominal obesity according to International Diabetes Federation (IDF) definition
Exclusion
- Any medications
- history of cardiovascular disease
- history of diabetes
- history of psychiatric illness
Key Trial Info
Start Date :
September 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2014
Estimated Enrollment :
77 Patients enrolled
Trial Details
Trial ID
NCT01180231
Start Date
September 1 2010
End Date
September 1 2014
Last Update
November 5 2013
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
BakerIDI Heart and Diabetes Institute
Prahran, Victoria, Australia, 3004
2
BakerIDI Heart and Diabetes Institute
Prahran, Victoria, Australia, 3004